A new PNAS paper reports cannabidiol can help reduce epileptic seizures and improve social behaviors in children with Dravet syndrome.
According to researchers, Cannabidiol, an active compound in cannabis plants, could help to alleviate cognitive impairment in people with schizophrenia.
Brain and fetal development damage caused by exposure to CBD and THC are very similar defects seen in fetal alcohol syndrome.
Classical music exposure paired with ibuprofen reduced response to inflammation pain by 93%, compared to exposure to the medication alone in mouse models of pain. For those exposed to just music, researchers report a 77% reduction in surgical pain.
H2CBD, a synthetic version of the cannabis compound CBD, has been found to be effective in decreasing the number and severity of seizures in rats.
Results from a phase 3 study reveal Cannabidiol (CBD) cuts seizures by almost 50% in children with Dravet syndrome.
A new study reports cannabidiol, a marijuana derivative, is effective at reducing seizure frequency in children and adults with treatment resistant epilepsy.
Cannabidiol (CBD) can inhibit aggressiveness associated with social isolation, a new mouse model study reveals.
Cannabidiol may be able to bypass the blood-brain barrier to effectively deliver medications directly to the brain.
Study finds no evidence to suggest cannabis helps patients with opioid use disorder to stop using opioids.
KLS-13019, a novel CBD analog, shows promise at reversing pain sensitivity and preventing symptoms of neuropathy in mouse models of chemotherapy-induced peripheral neuropathy.
A new study reveals the potency of THC in both herbal cannabis and cannabis resin has increased significantly in Europe since 2006.
